Gainers & Losers
Fri Jan 16 2026 10:20:19- Infosys share price
- ₹1,689.405.65%
- Tech Mahindra share price
- ₹1,670.555.17%
- Tata Consultancy Services share price
- ₹3,206.701.92%
- HCL Technologies share price
- ₹1,698.901.82%
- State Bank of India share price
- ₹1,042.301.36%
Active Stocks
Fri Jan 16 2026 10:29:29- Yes Bank share price
- ₹23.462.22%
- Suzlon Energy share price
- ₹48.50-1.04%
- Kotak Mahindra Bank share price
- ₹418.25-0.65%
- Indus Towers share price
- ₹434.00-0.98%
- Federal Bank share price
- ₹270.359.50%
Business News/Market/Market Stats/Caplin Point Laboratories share price/ Caplin Point Laboratories Profit Loss Annual
Caplin Point Laboratories Profit & Loss Annual
1,820.00 -34.20 (-1.84%)Updated : 16 Jan 2026
| Fiscal Period | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Period End Date | Mar 25 | Mar 24 | Mar 23 | Mar 22 |
| Total Operating Expense | 1,352.55 | 1,195.18 | 1,069.96 | 921.33 |
| Other Net | 6.81 | 5.18 | 5.12 | 3.08 |
| Diluted Weighted Average Shares | 7.63 | 7.63 | 7.65 | 7.64 |
| Gain( Loss)on Saleof Assets | -3.76 | -0.65 | -0.36 | 0.12 |
| Depreciation/ Amortization | 65.96 | 53.44 | 44.99 | 46.90 |
| Operating Income | 584.92 | 498.92 | 396.77 | 348.08 |
| Net Income | 536.31 | 457.09 | 376.26 | 299.84 |
| Income Availableto Com Excl Extra Ord | 536.31 | 457.09 | 376.26 | 299.84 |
| Net Income Before Taxes | 676.78 | 564.43 | 451.35 | 385.82 |
| Minority Interest | -4.78 | -4.33 | -0.73 | -8.61 |
| Net Income After Taxes | 541.09 | 461.42 | 376.99 | 308.45 |
| Income Availableto Com Incl Extra Ord | 536.31 | 457.09 | 376.26 | 299.84 |
| Costof Revenue Total | 815.80 | 762.91 | 694.80 | 581.85 |
| Gross Profit | 1,121.67 | 931.19 | 771.93 | 687.56 |
| Interest Inc( Exp) Net- Non- Op Total | 88.81 | 60.98 | 49.82 | 34.54 |
| Unusual Expense( Income) | 0.00 | - | - | 0.00 |
| Diluted Net Income | 536.31 | 457.09 | 376.26 | 299.84 |
| DPS- Common Stock Primary Issue | 6.00 | 5.00 | 4.50 | 4.00 |
| Provisionfor Income Taxes | 135.69 | 103.01 | 74.36 | 77.37 |
| period Type | - | - | - | - |
| Net Income Before Extra Items | 536.31 | 457.09 | 376.26 | 299.84 |
| Total Revenue | 1,937.47 | 1,694.10 | 1,466.73 | 1,269.41 |
| period Length | 12.00 | 12.00 | 12.00 | 12.00 |
| Revenue | 1,937.47 | 1,694.10 | 1,466.73 | 1,269.41 |
| Selling/ General/ Admin Expenses Total | 394.11 | 305.11 | 266.98 | 233.31 |
| Diluted Normalized EPS | 70.64 | 59.97 | 49.22 | 39.25 |
| Research Development | 76.68 | 73.72 | 63.19 | 59.27 |
| Diluted EPS Excluding Extra Ord Items | 70.25 | 59.90 | 49.18 | 39.26 |
*All figures in crores except per share values
Caplin Point Laboratories Quick Links
Caplin Point Laboratories Dividend Caplin Point Laboratories Bonus Caplin Point Laboratories News Caplin Point Laboratories AGM Caplin Point Laboratories Rights Caplin Point Laboratories Splits Caplin Point Laboratories Board Meetings Caplin Point Laboratories Key Metrics Caplin Point Laboratories Shareholdings Caplin Point Laboratories Balance Sheet Caplin Point Laboratories Cashflow Caplin Point Laboratories Q1 Results Caplin Point Laboratories Q2 Results Caplin Point Laboratories Q3 Results Caplin Point Laboratories Q4 Results
Equity Quick Links
Top GainersTop LosersIndian IndicesBSE Active StocksNSE Active Stocks
1,690.90+91.85(5.74%)
1,671.00+82.50(5.19%)
3,209.40+63.10(2.01%)
287.45-11.75 (-3.93%)
2,752.00-63.35 (-2.25%)